Theratechnologies Current ratio
Cos'è Current ratio di Theratechnologies?
Current ratio di Theratechnologies Inc. è 1.05
Qual è la definizione di Current ratio?
Il rapporto corrente è un rapporto di liquidità che misura se una società dispone o meno di risorse sufficienti per soddisfare i suoi obblighi a breve termine.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio di aziende nel Health Care settore su NASDAQ rispetto a Theratechnologies
Cosa fa Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Aziende con current ratio simili a Theratechnologies
- SPML Infra ha Current ratio di 1.05
- The Interpublic of Companies ha Current ratio di 1.05
- New Germany Fund Inc ha Current ratio di 1.05
- Polyspin Exports ha Current ratio di 1.05
- One Point One Solutions ha Current ratio di 1.05
- Apex Resources ha Current ratio di 1.05
- Theratechnologies ha Current ratio di 1.05
- Compagnie d'Entreprises CFE SA ha Current ratio di 1.05
- Bio-Thera Solutions ha Current ratio di 1.05
- Binjiang Services Co ha Current ratio di 1.05
- Canadian Imperial Bank Of Commerce ha Current ratio di 1.05
- Morningstar Inc ha Current ratio di 1.05
- Waitr Inc ha Current ratio di 1.05